These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3602697)

  • 1. [Antithrombin III levels in patients with acute thromboembolism during treatment with heparin].
    Barja P; Araya MV; Hassi M
    Rev Med Chil; 1986 Dec; 114(12):1160-3. PubMed ID: 3602697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of perioperative thromboembolism and antithrombin III levels in patients who are to undergo major gynecologic operations].
    Viceić M; Janković D; Bernat T; Vecek N; Ljubojević N
    Lijec Vjesn; 1988 Nov; 110(11):359-60. PubMed ID: 3231001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients].
    Oguma Y; Hasegawa H; Nagata H; Kawakami Y
    Rinsho Ketsueki; 1986 May; 27(5):723-9. PubMed ID: 3747167
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.
    Schulman S; Tengborn L
    Thromb Haemost; 1992 Dec; 68(6):634-6. PubMed ID: 1287876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins.
    Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Wilhelmsson S
    Thromb Res; 1984 May; 34(4):333-40. PubMed ID: 6740566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombin III control in patients with long-term anticoagulant therapy].
    Hönig JF; Merten HA; Korth O; Halling F; Köstering H
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
    Hoffmann JN; Wiedermann CJ; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Warren BL; Opal SM;
    Thromb Haemost; 2006 May; 95(5):850-6. PubMed ID: 16676077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the risk of postpartum thromboembolism by measuring antithrombin III levels. A false hope].
    Massignon D; Clerc-Renaud P; Desenfant H; Coeur P; Dumont M
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):171-2. PubMed ID: 3722743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III in patients with acute myocardial infarct in relation to fibrinolytic therapy].
    Soska V; Lupínek Z
    Vnitr Lek; 1987 Mar; 33(3):230-4. PubMed ID: 3660676
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K dependent clotting factors and their inhibitor--with special reference to prothrombin and antithrombin III.
    Gonmori H; Tsukada H; Takada M; Tanaka H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1466-78. PubMed ID: 7342649
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
    Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose heparin in elective abdominal surgery. Correlation between concentrations of heparin, antithrombin III and antiplasmin in patients with and without DVT.
    Kruse-Blinkenberg HO; Gormsen J; Jensen J; Thomsen F; Wille-Jørgensen P
    Acta Chir Scand; 1980; 146(6):383-90. PubMed ID: 7008476
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombo-embolic disease as a complication of nephrotic syndrome in children].
    Jarmoliński T; Zachwieja J; Bortkiewicz E; Stachowski J; Maciejewski J
    Pediatr Pol; 1996 May; 71(5):437-41. PubMed ID: 8710427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
    Lee AY; Rickles FR; Julian JA; Gent M; Baker RI; Bowden C; Kakkar AK; Prins M; Levine MN
    J Clin Oncol; 2005 Apr; 23(10):2123-9. PubMed ID: 15699480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.